151 related articles for article (PubMed ID: 21658725)
1. DITPA, a thyroid hormone analog, reduces infarct size and attenuates the inflammatory response following myocardial ischemia.
Abohashem-Aly AA; Meng X; Li J; Sadaria MR; Ao L; Wennergren J; Fullerton DA; Raeburn CD
J Surg Res; 2011 Dec; 171(2):379-85. PubMed ID: 21658725
[TBL] [Abstract][Full Text] [Related]
2. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.
Montecucco F; Lenglet S; Braunersreuther V; Pelli G; Pellieux C; Montessuit C; Lerch R; Deruaz M; Proudfoot AE; Mach F
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1371-7. PubMed ID: 20413731
[TBL] [Abstract][Full Text] [Related]
3. The effects of a thyroid hormone analog on left ventricular performance and contractile and calcium cycling proteins in the baboon.
Hoit BD; Pawloski-Dahm CM; Shao Y; Gabel M; Walsh RA
Proc Assoc Am Physicians; 1997 Mar; 109(2):136-45. PubMed ID: 9069582
[TBL] [Abstract][Full Text] [Related]
4. A thyroid hormone analog stimulates angiogenesis in the post-infarcted rat heart.
Tomanek RJ; Zimmerman MB; Suvarna PR; Morkin E; Pennock GD; Goldman S
J Mol Cell Cardiol; 1998 May; 30(5):923-32. PubMed ID: 9618233
[TBL] [Abstract][Full Text] [Related]
5. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
Arslan F; Smeets MB; O'Neill LA; Keogh B; McGuirk P; Timmers L; Tersteeg C; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
Circulation; 2010 Jan; 121(1):80-90. PubMed ID: 20026776
[TBL] [Abstract][Full Text] [Related]
6. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.
Dewald O; Zymek P; Winkelmann K; Koerting A; Ren G; Abou-Khamis T; Michael LH; Rollins BJ; Entman ML; Frangogiannis NG
Circ Res; 2005 Apr; 96(8):881-9. PubMed ID: 15774854
[TBL] [Abstract][Full Text] [Related]
7. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury.
Bao W; Hu E; Tao L; Boyce R; Mirabile R; Thudium DT; Ma XL; Willette RN; Yue TL
Cardiovasc Res; 2004 Feb; 61(3):548-58. PubMed ID: 14962485
[TBL] [Abstract][Full Text] [Related]
9. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
10. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.
Abbate A; Salloum FN; Vecile E; Das A; Hoke NN; Straino S; Biondi-Zoccai GG; Houser JE; Qureshi IZ; Ownby ED; Gustini E; Biasucci LM; Severino A; Capogrossi MC; Vetrovec GW; Crea F; Baldi A; Kukreja RC; Dobrina A
Circulation; 2008 May; 117(20):2670-83. PubMed ID: 18474815
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice.
Van Tassell BW; Varma A; Salloum FN; Das A; Seropian IM; Toldo S; Smithson L; Hoke NN; Chau VQ; Robati R; Abbate A
J Cardiovasc Pharmacol; 2010 Feb; 55(2):117-22. PubMed ID: 19920765
[TBL] [Abstract][Full Text] [Related]
12. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice.
Yamada K; Sakurai E; Itaya M; Yamasaki S; Ogura Y
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1839-43. PubMed ID: 17389519
[TBL] [Abstract][Full Text] [Related]
14. Regulation of gene expression in rats with heart failure treated with the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) and the combination of DITPA and captopril.
Maitra N; Adamson C; Greer K; Klewer S; Hoying J; Bahl JJ; Goldman S; Morkin E
J Cardiovasc Pharmacol; 2007 Nov; 50(5):526-34. PubMed ID: 18030062
[TBL] [Abstract][Full Text] [Related]
15. Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice.
Kobara M; Noda K; Kitamura M; Okamoto A; Shiraishi T; Toba H; Matsubara H; Nakata T
Cardiovasc Res; 2010 Aug; 87(3):424-30. PubMed ID: 20211866
[TBL] [Abstract][Full Text] [Related]
16. Protection of ischemic/reperfused canine myocardium by CL18/6, a monoclonal antibody to adhesion molecule ICAM-1.
Hartman JC; Anderson DC; Wiltse AL; Lane CL; Rosenbloom CL; Manning AM; Humphrey WR; Wall TM; Shebuski RJ
Cardiovasc Res; 1995 Jul; 30(1):47-54. PubMed ID: 7553723
[TBL] [Abstract][Full Text] [Related]
17. CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice.
Montecucco F; Braunersreuther V; Lenglet S; Delattre BM; Pelli G; Buatois V; Guilhot F; Galan K; Vuilleumier N; Ferlin W; Fischer N; Vallée JP; Kosco-Vilbois M; Mach F
Eur Heart J; 2012 Aug; 33(15):1964-74. PubMed ID: 21606075
[TBL] [Abstract][Full Text] [Related]
18. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
[TBL] [Abstract][Full Text] [Related]
19. In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury.
Lomas-Neira JL; Chung CS; Wesche DE; Perl M; Ayala A
J Leukoc Biol; 2005 Jun; 77(6):846-53. PubMed ID: 15695553
[TBL] [Abstract][Full Text] [Related]
20. CXC chemokine KC fails to induce neutrophil infiltration and neoangiogenesis in a mouse model of myocardial infarction.
Oral H; Kanzler I; Tuchscheerer N; Curaj A; Simsekyilmaz S; Sönmez TT; Radu E; Postea O; Weber C; Schuh A; Liehn EA
J Mol Cell Cardiol; 2013 Jul; 60():1-7. PubMed ID: 23598282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
